levofloxacin has been researched along with quercetin 3-o-glucopyranoside in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (quercetin 3-o-glucopyranoside) | Trials (quercetin 3-o-glucopyranoside) | Recent Studies (post-2010) (quercetin 3-o-glucopyranoside) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 131 | 0 | 86 |
| Protein | Taxonomy | levofloxacin (IC50) | quercetin 3-o-glucopyranoside (IC50) |
|---|---|---|---|
| alkaline phosphatase, intestinal | Homo sapiens (human) | 7.105 | |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | Homo sapiens (human) | 14 | |
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 1.66 | |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 0.95 | |
| Arginase | Leishmania amazonensis | 2 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 4.4 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 4.5 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalra, S; Khatik, GL; Kumar, GN; Kumar, R; Narang, R; Nayak, SK; Singh, SK; Sudhakar, K | 1 |
1 review(s) available for levofloxacin and quercetin 3-o-glucopyranoside
| Article | Year |
|---|---|
Recent advancements in mechanistic studies and structure activity relationship of F
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Proton-Translocating ATPases; Structure-Activity Relationship | 2019 |